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Abstract Experiments conducted in space in the last two
decades have shown that T lymphocyte activation in vitro is
remarkably reduced in microgravity. The data indicate that a
failure of the expression of the interleukin-2 receptor (measured
as protein secreted in the supernatant) is responsible of the loss of
activity. To test such hypothesis we have studied the genetic
expression of interleukin-2 and of its receptor in concanavalin A-
activated lymphocytes with the RT-PCR technology. Micro-
gravity conditions were simulated in the fast rotating clinostat
and in the random positioning machine. The latter is an
instrument introduced recently to study gravitational effects on
single cells. Our data clearly show that the expression of both IL-
2 and IL-2RK genes is significantly inhibited in simulated 0Ug.
Thus full activation is prevented.
z 1998 Federation of European Biochemical Societies.
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1. Introduction
Several in vitro studies conducted in space and in simulated
microgravity on ground have shown unexpected alterations of
T lymphocyte function, reviewed in [1,2]. In fact, in an experi-
ment conducted in Spacelab 1 in 1983 we observed a near
total (97%) loss of activation in peripheral blood leukocytes
exposed to concanavalin A (Con A) compared to identical
ground controls [3]. Such ¢nding was con¢rmed later in sev-
eral Spacelab £ights as D-1 in 1985, SLS-1 in 1991, IML-2 in
1994 whereby controls were incubated in an in-£ight 1Ug
reference centrifuge. A systematic approach to understand
the causes of the loss of activation was conducted in space,
in sounding rockets, and in microgravity simulations in the
fast rotating clinostat (FRC). Our ¢ndings can be summarized
as follows: Mitogenic activation, measured as the mitotic in-
dex after 3 days of incubation, is reduced between 98^50% at
0Ug when compared to 1Ug controls either in space or on
the ground [1,2]; while the binding of Con A to membrane
glycoproteins is unchanged, patching and capping are slightly
retarded at 0Ug [4] ; cell-cell interactions as well as autono-
mous cell movements are occurring at 0Ug, although in slight
lesser extent than at 1Ug [5] ; surprisingly, the production of
interleukin-1 (IL-1) by monocytes as accessory cells is en-
hanced at 0Ug [6] ; changes of the structure of micro¢laments
(vimentin) occur already 30 s after exposure to microgravity
[4] ; the amount of interleukin-2 receptor (IL-2R) measured as
protein secreted in the medium is strongly depressed at 0Ug
[7] ; the secretion of interleukin-2 (IL-2) in the medium is also
reduced at 0Ug [7]. Such ¢ndings support the hypothesis that
an alteration of the IL-2/IL-2R function may be the cause of
the e¡ects.
The behavior of lymphocytes in microgravity has been
studied also by other investigators. In particular, in an experi-
ment with human leukocytes activated with phorbol esters
conducted by Schmitt et al. [8] in Spacelab IML-2 it was
shown that the distribution of PKC, a key element of the
signal transduction of T cells, is altered in microgravity. Re-
cently, Cooper and Pellis reported that the loss of activation
of T cells in microgravity, simulated in a device called rotating
wall vessel, was restored by direct activation of PKC with
phorbol myristate [9]. However, such restoration was only
partial under optimum activation conditions. We also disagree
with Cooper and Pellis’ interpretation that lack of cell-cell
contacts contribute signi¢cantly to the loss of activity at 0Ug.
A depression of mitogenic activation, compared to the pre-
£ight (14 days before launch) and post-£ight baseline (7 days
after landing) has also been measured ex vivo in PBL drawn
from space crew members during (3rd day in orbit) and im-
mediately (1 h) after £ight, whereby the in-£ight cultures were
incubated in centrifuge at 1Ug. However, our and others’
studies clearly indicate that the e¡ects observed in vitro are
real gravitational e¡ects occurring at the cellular level, where-
as the ex vivo e¡ects are caused by the physical and psycho-
logical stress of space £ight on the immune system via the
neuroendocrine system, reviewed in [10^12].
In vitro studies in microgravity have provided a useful tool
towards the understanding of the complex activation mecha-
nism of T lymphocytes. In fact, microgravity can be used as a
non-invasive inhibitor of cell activation.
IL-2 and IL-2R play a crucial role as third signal in T cell
activation whereby the ¢rst signal is delivered either by the
antigen-presenting cell, or by a mitogen such as Con A, or by
anti-CD3; the second signal is either anti-CD28 or IL-1. Only
upon the interaction between IL-2 and IL-2R the full activa-
tion of T lymphocytes is triggered. Cells start to divide and
two populations, the e¡ector and the memory cells, are gen-
erated.
In this context, there is strong interest today in the study of
the genetic expression of the IL-2R in human tumor cells as
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IL-2 may be used in cancer therapy to inhibit tumor cellular
proliferation [13].
The objective of the work described here was to test the IL-
2/IL-2R dysfunction hypothesis by studying the e¡ect of sim-
ulated microgravity on the genetic expression of IL-2 and of
its receptor. Two instruments were used to simulate micro-
gravity. One is the FRC proposed long ago by Muller [14],
and developed by Briegleb [15] on the base of the calculations
of Silver [16]; the other is the random positioning machine
(RPM), called also three-dimensional clinostat. The RPM has
been developed by Hoson at the Osaka City University [17,18]
and has been used for the study of plant gravitropism. This is
the ¢rst report on the use of the RPM with single cells. The
main advantages of the RPM compared to the FRC are the
larger number and volume of cultures that can be processed in
one experiment cycle and the three-dimensional versus the
uni-dimensional rotation.
2. Materials and methods
2.1. Microgravity simulations
The FRC has been manufactured in our workshop as described
earlier [19]. It consists of a tube of 0.8 cm diameter and 100 cm length
rotating around its longitudinal axis at speed of 90 rpm. Cell cultures
were sealed in tubes made of Te£on of 0.45 cm diameter and 10 cm
length.
The RPM was developed by Fokker Space, Leiden, The Nether-
lands. In principle, probes are ¢xed as close as possible to the center
of a frame. This frame is rotating within a second rotating frame.
Both frames are driven by separate motors. Rotation of each frame
is random and autonomous and regulated by computer software. The
rotation velocity of the frames was 60‡ s31. The RPM was located in a
37‡C room. A box containing the cell cultures sealed in Eppendorf
tubes was installed on the center of the inner frame of the RPM.
Although real microgravity is attained only in orbital laboratories
such machine o¡ers an inexpensive and suitable instrument for simu-
lation in the ground laboratory (Schwarzenberg et al., submitted for
publication). Control (static) cultures were installed on the basement
of the RPM.
2.2. Lymphocyte isolation
Peripheral blood lymphocytes were puri¢ed from bu¡y-coat prepa-
rations (Blood bank, Red Cross, Zurich or Sassari) diluted 1:10 with
Hanks bu¡er by gradient centrifugation on Ficoll-Hypaque. Cell via-
bility was assessed by £uorescein-diacetate-positive test (0.002% FDA
in PBS). The cells were stored at ambient temperature for at least 4 h
prior to activation. This allows the cells to recover from the stress of
the isolation. In fact, centrifugation steps lasting 10^30 min at 200Ug
or more may activate certain genes and thus cause artefacts due to
hypergravity stress.
2.3. Lymphocyte activation
The cells were resuspended at a concentration of 107 ml31 in RPMI
1640 (Sigma) supplemented with 40 mM HEPES, 5 mM sodium bi-
carbonate, gentamycine (50 Wg ml31), and 10% heat-inactivated fetal
calf serum (mycoplasma-free, Gibco). T cells were activated by addi-
tion of Con A at a ¢nal concentration of 10 Wg ml31. To avoid the
presence of large air bubbles, which could lead to shear force damages
of the cells on the RPM, the 2 ml Eppendorf tubes were completely
¢lled. The cells were activated for periods between 0 and 12 h as
shown in the ¢gures.
2.4. mRNA extraction and RT-PCR
After incubation, the cells were pelleted by short centrifugation, the
supernatant was discarded and the cells were immediately lysed by
addition of the lysing bu¡er. The semi-quantitative RT-PCR analyses
were performed either with (a) total cellular RNA (IL-2RK, L-actin);
or (b) mRNA (IL-1, IL-2, IL-2RK, IL-2RL, L-actin).
(a) Total cellular RNA was isolated by a method developed by M.
Hughes-Fulford (personal communication) based on guanidine thio-
cyanate and adapted to the working conditions particular of space
laboratories. The RNA concentrations were measured spectrophoto-
metrically. Typically, 800 ng of the total RNA were reverse-tran-
scribed with random hexamers or oligo dT for priming and the
Gene Amp RNA PCR kit (Perkin Elmer, N808-0143). A fourth of
the RT reaction was used for PCR ampli¢cation in a total volume
of 50 Wl. IL-2RK and L-actin transcripts were ampli¢ed with speci¢c
primers following the supplier’s instruction (Stratagene). The PCR
products were separated by electrophoresis with EtBr, the gels were
photographed and digitalized by densitometry (Imaging Densitometer
GS-700, BioRad). Analysis of the band intensity was performed with
the software Molecular Analyst 2.1.1 (BioRad) The results of the IL-
2RK expression were standardized by comparison with the expression
of the constitutively expressed L-actin.
(b) Cellular RNA was ¢rst isolated with a modi¢ed guanidine thi-
ocyanate method (guanidine thiocyanate 8 M/Triton 1%), then
mRNA was captured by a silica-based resin and resuspended in water
(Nurex, Sassari, Italy). The totality of the mRNA was reverse-tran-
scribed with oligo dT and a commercial kit. cDNA was synthesized
during 1 h incubation at 37‡C. A ¢fth of the reaction was used for
each speci¢c ampli¢cation (IL-1, IL-2, IL-2RK, IL-2RL, and L-actin).
PCR ampli¢cation was performed with 1 U of Taq DNA polymerase
(Life Technologies) in a ¢nal volume of 25 Wl. Primer sequences and
annealing temperatures were as already described [20]. Ampli¢ed
DNA was cross-linked to prevent cross-contamination and stained
in a stable manner by DNA Block and Stain (Nurex, Sassari, Italy).
Fluorescent stained DNA was separated by agarose gel electrophore-
sis and gel intensity was determined by densitometric measurement of
the speci¢c bands.
The optimal number of ampli¢cation cycles for each primer set was
chosen in the exponential phase of ampli¢cation, which was deter-
mined experimentally by measuring the amount of speci¢c products
after every two cycles between 20 and 35.
3. Results and discussion
In this study ¢ve independent experiments, i.e. with the
blood of ¢ve donors, were performed either on the RPM or
in the FRC. The data obtained with both machines are con-
sistent. We have shown that the results obtained with the
FRC [1] and with the RPM (Schwarzenberg et al., manuscript
submitted for publication) are in agreement with those ob-
tained in space. In addition, we have used two di¡erent meth-
ods to purify and process the RNA. Both methods gave also
consistent results.
3.1. IL-2 expression
In an experiment conducted earlier in space we found after
a 46 h incubation at 0Ug a lower level of IL-2 (600 pg ml31)
than in 1Ug controls, either in a 1Ug reference centrifuge in-
£ight (920 pg ml31) or on ground (800 pg ml31, [7]). After
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Fig. 1. E¡ect of simulated microgravity on the genetic expression of
IL-2. The data shown here are from one experiment in the FRC
and are consistent with another in the FRC and with three analo-
gous experiments on the RPM.
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65 h, however, the amount of IL-2 remained unchanged at
0Ug, whereas it was reduced to nearly 0 in both 1Ug con-
trols. The activation of the T cells, measured as tritiated thy-
midine incorporated into DNA, was reduced by 85% after 46 h
at 0Ug and by 50% after 65 h compared to the 1Ug controls.
These data indicated, ¢rst, that there was a reduced synthesis/
secretion of IL-2 at 0Ug ; second that activated cells (at 1Ug)
bound all IL-2 available in the culture medium, whereas the
IL-2 was not taken up at 0Ug. Moreover it was seen in two
space £ights that the amount of IL-2R in the supernatant of
the 0Ug samples was reduced by 95 and 74%, respectively,
compared to the 1Ug in-£ight and ground controls [6,7]. Such
depression observed in T cells at 0Ug could be due either to a
reduction of genetic expression, or of secretion, or of uptake/
insertion in the membrane of IL-2 and IL-2R.
The data in Fig. 1 show that the onset of genetic expression
of IL-2 in Con A-activated cells begins approximately 1 h
after exposure to the mitogen at 1Ug as well as in simulated
microgravity conditions; however, there is a clear inhibition at
0Ug, ranging after 6 h from 20 to 50% in the ¢ve experiments
performed. We believe now that this inhibition contributes to
the decrease of T cell response at 0Ug.
The regulation of the transcription of the IL-2 gene is based
on complex and still obscure mechanisms involving transcrip-
tion factors such as NFAT, AP-1, NF-UB and other and it is
today object of extensive studies, reviewed recently in [21,22].
In addition, the T cell response may di¡er depending on the
nature of the ¢rst and the second (co-stimulatory) signals as
recently shown by Kalli et al. with either anti-CD3-IL-1 or
anti-CD3-anti-CD28 as activators [23]. The question now is
what causes the reduction of genetic expression of IL-2. This
can be due to the alterations of the PKC seen by Schmitt et al.
[8] in space; or to a disturbance of signal transduction up-
stream of the PKC regulation as described by Cooper and
Pellis [9] in experiments conducted in a rotating wall vessel ;
or, ¢nally, either to a dysfunction of the regulation of the
transcription of the IL-2 gene or of the posttranscriptional
stabilization of IL-2 mRNA as discussed by Kalli et al. [23]
and by Lindsten et al. [24].
3.2. IL-2R expression
The IL-2 receptor consists of three protein chains. The K-
subunit is responsible, in association with the L- and Q-chains,
of the high a⁄nity of the receptor toward IL-2, but only the
L-chain and Q-chain are involved in the intracellular signal
transduction [25]. Also the regulation of the IL-2K expression
is a complex and not yet completely understood process [26].
In our investigation of the IL-2R, we focused our attention on
the K- and L-chains only, because the Q-chain is constitutively
expressed. The expression of the K-chain is also signi¢cantly
inhibited (Fig. 2), though the range of the percentage (15^70%
after 6 h) of inhibition in the ¢ve experiments performed is
larger than that of IL-2. The reason of such variation is not
clear, but it might be due to a higher instability of the IL-2RK
speci¢c mRNA. It is important to notice that, in contrast to
IL-2, IL-2R expression is not under PKC regulation [26].
Interestingly enough, the expression of the L-chain is not
in£uenced by simulated microgravity (Fig. 3). Therefore, the
intracellular signal mediated by the L-chain is not the in£u-
encing factor in the depression of the lymphocyte activation in
microgravity. This is similar to what has been shown by Su-
minami et al. [13] : the growth inhibition of carcinoma cell
lines by exogenous IL-2 was not due to di¡erent forms of
the IL-2R L-chain.
3.3. IL-1 expression
Interleukin-1 is important in the mediation of the second
signal in the activation of lymphocytes. In a previous experi-
ment in space, we found that its production was increased at
0Ug [6]. Such ¢nding was con¢rmed by Cooper and Pellis in
the rotating wall vessel [9]. Also the results obtained at the
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Fig. 2. E¡ect of simulated microgravity on the genetic expression of
IL-2RK. The data shown here are from one experiment on the
RPM and are consistent with four analogous experiments on the
RPM.
Fig. 3. E¡ect of simulated microgravity on the genetic expression of
IL-2RL. The data shown here are from one experiment on the
RPM and are consistent with another analogous experiment in the
FRC.
Fig. 4. E¡ect of simulated microgravity on the genetic expression of
IL-1. The data shown here are from one experiment on the RPM
and are consistent with another analogous experiment in the FRC.
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molecular level (Fig. 4) show that the IL-1 expression is en-
hanced on the RPM in comparison to the 1Ug control. This
excludes also the possibility that the reduction in the expres-
sion of the other genes was due to a mechanical damage of the
cells on the RPM or in the FRC.
4. Conclusions
The data presented here together with our previous studies
permit us to conclude that either at 0Ug or under simulated
microgravity conditions: (i) the binding of Con A is unaf-
fected as seen in sounding rockets, however the process of
patching and capping is slightly retarded [4]; (ii) the secretion
and the genetic expression of IL-2 is inhibited [6,7] ; (iii) the
secretion and the genetic expression of IL-1 is enhanced [6] ;
(iv) the secretion of the IL-2 receptor is reduced at 0Ug [7] ;
(v) the activation of IL-2RK gene is signi¢cantly depressed in
simulated 0Ug whereas that of the IL-2RL is not a¡ected.
Based on such ¢ndings and those of Cooper and Pellis we
suggest that di¡erent events contribute synergistically to the
loss of activity of T cells in microgravity. The most important
are the dysfunction of the transcription of the IL-2R gene and
of the signal transduction upstream of PKC.
This work helped to clarify an important aspect of the in-
hibition of signal transduction in T cells in microgravity. We
believe that this approach may also contribute to the further
understanding of the complex activation mechanism. More-
over, the RPM has proven to be a useful tool to simulate
microgravity in the ground laboratory and to prepare space
investigation. In fact, we will continue our study of the genetic
expression during T lymphocyte activation with an experiment
selected with high priority by NASA and ESA for a £ight
scheduled in the year 2000.
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